Latest debt-to-equity ratio
Cellyan Biotechnology Debt-to-equity ratio
Direct answer
Cellyan Biotechnology's debt-to-equity ratio is 13.13%.
The verified market snapshot reports 13.13%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 20, 2026.
Get free Cellyan Biotechnology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 13.13%
Explore related company data
View Cellyan Biotechnology's market capitalizationView Cellyan Biotechnology's price-to-book ratioView Cellyan Biotechnology's return on equityView Cellyan Biotechnology's dividend yieldView Cellyan Biotechnology's 52-week price rangeView Cellyan Biotechnology's revenue growthView Cellyan Biotechnology's profit marginView all Cellyan Biotechnology key metricsReturn to Cellyan Biotechnology profile